Home/Pipeline/Recurrent Brain Metastases after SRS Trial

Recurrent Brain Metastases after SRS Trial

Radiographically Progressive Brain Metastases after Stereotactic Radiosurgery

Randomized Controlled TrialActive (Enrolling)

Key Facts

Indication
Radiographically Progressive Brain Metastases after Stereotactic Radiosurgery
Phase
Randomized Controlled Trial
Status
Active (Enrolling)
Company

About Monteris Medical

Monteris Medical is a private medical device company and the established leader in MRI-guided laser ablation for the brain. Its core technology, the NeuroBlate System, is the only robotic LITT platform designed specifically for neurosurgical applications, enabling precise, real-time thermal ablation of targeted brain tissue. The company has built a significant body of prospective clinical evidence, including the landmark LAANTERN registry and a first-of-its-kind randomized controlled trial for recurrent brain metastases, to drive clinical adoption. Monteris operates in the high-growth neurosurgery and neuro-oncology markets, focusing on providing a less invasive alternative to open brain surgery.

View full company profile